BRCA1/2 Mutations May Decrease Lifespan Even In The Absence of Cancer
BRCA1 and BRCA2 (BRCA1/2) mutations account for most (though not all) cases of inherited breast cancer in women. These mutations are also associated with an increased risk for ovarian cancer. In men,...
View ArticleTalking about Breast Cancer
Do You Have a Story? How have you been affected by breast cancer? Tell us your story and help all of us learn more about the disease. (To share your story, please leave a comment at the end of this...
View Article23andMe Finds Few Negative Reactions to Genetic Tests For Cancer Mutations
We know from scientific research that, in general, people don’t freak out about the results they get from personal genetic testing. When the results show an increased risk for serious illness, how do...
View ArticleTalking About Breast Cancer Risk
Angelina Jolie’s revelation in the New York Times today that she had a double mastectomy after learning about her genetic risk for breast cancer focused attention on the difficult dilemma faced by...
View ArticleThe Power of Knowing
Ignorance isn’t always bliss and what you don’t know really can hurt you, or so Jennifer Goldstein has learned. If she hadn’t tested she might never have seen her doctor; never would have asked the...
View ArticleThis Year’s Top Ten Genetic Findings
Each year at this time 23andMe puts together a list of the most interesting genetic findings of 2013. We’re doing that again but with a twist. We want to include in our list a few things that aren’t...
View Article23andMe Looks Back One More Time
In honor of the Chinese New Year, we’re taking one last look at the genetic milestones of 2013. From a Supreme Court ruling on patenting genes, to Angelina Jolie’s bold revelations about her genetic...
View ArticleA Conversation With 23andMe Researcher Chao Tian
This interview is part of an occasional series of profiles introducing you to the people behind 23andMe’s compelling research. Chao Tian is a statistical geneticist, who came to 23andMe after studying...
View Article23andMe Finds Few Negative Reactions to Genetic Tests For Cancer Mutations
Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22,...
View ArticleBRCA1/2 Mutations May Decrease Lifespan Even In The Absence of Cancer
BRCA1 and BRCA2 (BRCA1/2) mutations account for most (though not all) cases of inherited breast cancer in women. These mutations are also associated with an increased risk for ovarian cancer.In men,...
View ArticleCustomer response to direct-access BRCA genetic testing
We know from scientific research that, in general, people don’t freak out about the results they get from personal genetic testing. When the results show an increased risk for serious illness, how do...
View ArticleTalking About Breast Cancer Risk
Angelina Jolie’s revelation in the New York Times today that she had a double mastectomy after learning about her genetic risk for breast cancer focused attention on the difficult dilemma faced by...
View ArticleThis Year’s Top Ten Genetic Findings
Each year at this time 23andMe puts together a list of the most interesting genetic findings of 2013. We’re doing that again but with a twist. We want to include in our list a few things that aren’t...
View Article23andMe Looks Back One More Time
In honor of the Chinese New Year, we’re taking one last look at the genetic milestones of 2013. From a Supreme Court ruling on patenting genes, to Angelina Jolie’s bold revelations about her genetic...
View ArticleA Conversation With 23andMe Researcher Chao Tian
This interview is part of an occasional series of profiles introducing you to the people behind 23andMe’s compelling research. Chao Tian is a statistical geneticist, who came to 23andMe after studying...
View Article23andMe: Five Things from 2018
Before we kick off the New Year, let’s look back and highlight a few important moments for us here at 23andMe in 2018.The Power of Big DataFor some types of research, size really does matter. In the...
View Article23andMe Returns to Salt Lake City for RootsTech 2019
It’s February, which means the largest family discovery conference of the year is almost upon us. This year, 23andMe will be returning to Salt Lake City, Utah for RootsTech 2019. The visit offers us a...
View ArticleA Major Milestone in Consumer Health Empowerment
We wear pink ribbons. We walk or run for the cause. We have a month for awareness, and yet many women who have a higher risk variant in the BRCA1 or BRCA2 genes remain unaware of their heightened...
View Article23andMe’s New BRCA1/BRCA2 Report
Last month 23andMe received the first-ever FDA authorization for a direct-to-consumer genetic health risk test for cancer. Eligible 23andMe Health + Ancestry Service customers now have the option to...
View ArticleBreast Cancer Awareness Month
October is Breast Cancer Awareness Month, a time to draw attention and support for the importance of early detection and treatment of this disease. As part of Breast Cancer Awareness Month, we are...
View Article
More Pages to Explore .....